EC approves Novartis’ skin cancer therapy combo Tafinlar and Mekinist for melanoma

In a significant development for melanoma treatment, the European Commission (EC) has granted Novartis approval for its combination therapy of Tafinlar (dabrafenib) and Mekinist (trametinib). ... Read More